MIRA
INFORM REPORT
|
Report Date : |
05.11.2008 |
IDENTIFICATION
DETAILS
|
Name : |
TRIVITRON HEALTHCARE PRIVATE LIMITED |
|
|
|
|
Formerly Known As : |
TRIVITRON DIAGNOSTICS PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Trivitron Sapthagiri Bhawan, No. 15, IV Street, Abhiramapuram, Chennai – 600018, Tamilnadu. |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as on) : |
31.03.2007 |
|
|
|
|
Date of Incorporation : |
18.05.1998 |
|
|
|
|
Com. Reg. No.: |
18-40515 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U85110TN1998PTC040515 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
CHET07271F /
CHET07756A |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACT9378H |
|
|
|
|
Legal Form : |
Private Limited Liability
Company |
|
|
|
|
Line of Business : |
Manufacturers of
Diagnostic Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
Aa |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
Maximum Credit Limit : |
USD 300000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well
established and reputed company having fine track. Trade relations are fair.
Financial position is good. Payments are usually correct and as per
commitments. The company can
be considered good for any normal business dealings. It can be regarded as a
promising business partner in a medium to long run. |
LOCATIONS
|
Registered Office/Factory: |
Trivitron Sapthagiri Bhawan, No. 15, IV Street, Abhiramapuram, Chennai – 600018, Tamil Nadu, India |
|
Tel. No.: |
91-44-24985050 /
28522216 / 28594817/ 24985151/ 5656 |
|
Fax No.: |
91-44-24985757 /
28548997 |
|
E-Mail : |
|
|
Website: |
|
|
|
|
|
Corporate Office : |
Trivitron Group of Companies. 15, IVth
Street, Abhiramapuram, Chennai - 600 018, Tamil Nadu, India. |
|
Tel. No.: |
91 - 44 - 2498 5050 (6 lines) |
|
Fax No.: |
91 - 44 - 2498 5757 / 2467 2782 |
|
E-Mail : |
|
|
|
|
|
Regional Offices: |
CHENNAI (Renal Care) NEW DELHI MUMBAI MUMBAI ( Diagnostics ) KOLKATA BANGALORE HYDERABAD PONDICHERRY |
|
|
|
|
Overseas Offices: |
SRI LANKA DUBAI |
|
|
|
|
Branches : |
NAGPUR THRISSUR AHMEDABAD COIMBATORE COCHIN PUNE CHANDIGARH JAIPUR LUCKNOW |
DIRECTORS
|
Name : |
Dr. G. S. K. Velu
|
|
|
Designation : |
Managing Director
|
|
|
Address : |
No. 25 (Old No.
13), 1st Main Road, Cit Colony, Mylapore, Chennai – 600 004,
Tamilnadu, India. |
|
|
Date of Birth/Age : |
30.06.1967 |
|
|
Date of Appointment : |
28.01.1999 |
|
|
|
|
|
|
Name : |
Mrs. Subha K Velu
|
|
|
Designation : |
Director |
|
|
Address : |
No. 25 (Old No.
13), 1st Main Road, Cit Colony, Mylapore, Chennai – 600 004,
Tamilnadu, India. |
|
|
Date of Birth/Age : |
25.10.1972 |
|
|
Date of Appointment : |
27.01.1997 |
|
|
|
|
|
|
Name : |
Mr. Sameer D
Saral |
|
|
Designation : |
Director |
|
|
Address : |
C 3, Kosala No.
14, Srinivasa Road, T. Nagar, Chennai – 600 017, Tamilnadu, India. |
|
|
Date of Birth/Age : |
17.06.1963 |
|
|
Date of Appointment : |
27.01.1997 |
|
|
|
|
|
|
Name : |
Mr. Chandrasekhar Kandasamy |
|
|
Designation : |
Director |
|
|
Address : |
Villa 17, phase I, palm Meadows, Airports Whitefield Road, Bangalore –
560 066, Karnataka |
|
|
Date of Birth/Age : |
31.01.1967 |
|
|
Date of Appointment : |
31.10.2007 |
|
|
|
|
|
|
Name : |
Mr. James Frederick Savage |
|
|
Designation : |
Director |
|
|
Address : |
8A Block 18, Baguio Villas, 555 Victoria Road, Pok Fu Lam Hong Kong |
|
|
Date of Birth/Age : |
18.04.1969 |
|
|
Date of Appointment : |
31.10.2007 |
|
|
|
|
|
|
Name : |
Mr. Velu Kulandai Subbulakshmi |
|
|
Designation : |
Director |
|
|
Address : |
25, first Main road, CIT Colony , Mylapore, Chennai – 600 004, Tamil
Nadu |
|
|
Date of Birth/Age : |
25.10.1972 |
|
|
Date of Appointment : |
18.05.1998 |
|
KEY EXECUTIVES
|
Name : |
Mr. K Venugopalan |
|
Designation : |
Company Secretary |
|
Address : |
1st Floor, 22/3 Venkatarishna Road, Mandaveli, Chennai – 600 020 |
|
Tel No: |
91-44-42815423 |
|
Mobile: |
91-9840819356 |
|
Email: |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
|
Names of Shareholders |
|
No. of Shares |
|
Dr. GSK Velu |
|
620630 |
|
Mr. Sameer D Saral |
|
100 |
|
Mrs. Sudha K Velu |
|
100 |
|
|
Total
|
620830 |
Equity Shares Breakup (Percentage of Total Equity):
|
Sr No. |
Category |
Percentage |
|
1 |
Directors or relatives of directors |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturers of
Diagnostic Products |
|
|
|
|
Products : |
v
Immulite
Analyser v
Cell Counter
v
Blood Gas
Analyser v
Celly-Haematology
Analyser v
Others-Spares
and Consumables |
|
|
|
|
Exports to : |
Sri Lanka, Nepal,
Bangladesh |
|
|
|
|
Imports from : |
Europe, USA,
Japan |
|
|
|
|
Terms : |
|
|
Selling : |
L/C |
|
|
|
|
Purchasing : |
L/C DA |
GENERAL
INFORMATION
|
Suppliers : |
v
Hamilton
Medical , Switzerland v
Fresenius
Medical, Germany |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Customers : |
v
Sri
Ramchandra Medical College, Porur, Chennai v
All India Institute
of Medical Sciences, New Delhi |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Employees: |
150 |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Bankers: |
· ING Vysya Bank Limited, Address: 13/1, Karpagambal Nagar, Mylapore
Branch, Chennai – 600 004, Tamil Nadu, India · HDFC Bank Limited Address: Chennai – 600 002, Tamil Nadu,
India |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Banking Relations : |
Good |
||||||||||||||||||
|
|
|
||||||||||||||||||
|
Auditors : |
R Subramanian and
Company Chartered
Accountants |
||||||||||||||||||
|
Address: |
36, New No. 6, Krishnaswamy
Avenue Mylapore, Chennai – 600 004, Tamil Nadu, India |
||||||||||||||||||
|
Tel. No.: |
91-44-24992261/
1347/ 4231 |
||||||||||||||||||
|
Fax No.: |
91-44-24991408 |
||||||||||||||||||
|
Email: |
|||||||||||||||||||
|
|
|
||||||||||||||||||
|
Associates/Subsidiaries : |
Trivitron Medical
Systems Private Limited |
CAPITAL STRUCTURE
(As on
31.03.2008):-
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1100000 |
Equity shares |
Rs. 10/- each |
Rs. 11.000 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
810380 |
Equity shares |
Rs. 10/-
each |
Rs. 8.104
millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
6.208 |
6.208 |
4.208 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
66.099 |
42.233 |
24.688 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
72.307 |
48.441 |
28.896 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
32.355 |
9.483 |
4.995 |
|
|
2] Unsecured Loans |
2.096 |
0.992 |
1.433 |
|
|
TOTAL BORROWING |
34.451 |
10.475 |
6.428 |
|
|
DEFERRED TAX LIABILITIES |
1.625 |
1.384 |
1.340 |
|
|
|
|
|
|
|
|
TOTAL |
108.383 |
60.300 |
36.664 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
44.631 |
34.196 |
25.992 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
6.293 |
2.057 |
2.057 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
20.493
|
14.550 |
10.519 |
|
|
Sundry Debtors |
155.775
|
109.921 |
59.756 |
|
|
Cash & Bank Balances |
19.952
|
7.475 |
20.493 |
|
|
Other Current Assets |
0.322
|
0.301 |
0.149 |
|
|
Loans & Advances |
18.848
|
15.084 |
12.097 |
|
Total
Current Assets |
215.390
|
147.331 |
103.014 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Current Liabilities |
144.339
|
111.701 |
85.697 |
|
|
Provisions |
13.592
|
11.583 |
8.702 |
|
Total
Current Liabilities |
157.931
|
123.284 |
94.399 |
|
|
Net Current Assets |
57.459
|
24.047 |
8.615 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
108.383 |
60.300 |
36.664 |
|
PROFIT & LOSS
ACCOUNT
|
PARTICULARS |
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
|
Sales Turnover |
408.156 |
314.928 |
227.747 |
|
|
Other Income |
16.739 |
6.271 |
6.955 |
|
|
Total Income |
424.895 |
321.199 |
234.702 |
|
|
|
|
|
|
|
|
Profit/(Loss) Before Tax |
37.702 |
28.676 |
24.536 |
|
|
Provision for Taxation |
13.835 |
11.132 |
9.111 |
|
|
Profit/(Loss) After Tax |
23.867 |
17.544 |
15.425 |
|
|
|
|
|
|
|
|
Earnings in Foreign Currency : |
|
|
|
|
|
|
Export Earnings |
10.505 |
14.348 |
0.131 |
|
|
Commission Earnings |
1.364 |
0.843 |
6.182 |
|
Total Earnings |
11.869 |
15.191 |
6.313 |
|
|
|
|
|
|
|
|
Import Value |
275.716 |
194.782 |
142.986 |
|
|
|
|
|
|
|
|
Expenditures : |
|
|
|
|
|
|
Cost of Goods Sold |
291.224 |
218.657 |
151.500 |
|
|
Administrative Expenses |
88.770 |
71.085 |
56.964 |
|
|
Financial Charges |
2.029 |
0.955 |
0.868 |
|
|
Depreciation & Amortization |
5.170 |
1.826 |
0.834 |
|
sTotal Expenditure |
387.193 |
292.523 |
210.166 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2007 |
31.03.2006 |
31.03.2005 |
|
PAT / Total Income |
(%) |
5.61
|
5.46 |
6.57 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
9.23
|
9.10 |
10.77 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
14.49
|
15.79 |
19.01 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.52
|
0.59 |
0.84 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
2.66
|
2.76 |
3.48 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.36
|
1.19 |
1.09 |
LOCAL AGENCY
FURTHER INFORMATION
FORM 8:-
|
Corporation identity number or foreign company registrations number of
the company |
U85110TN1998PTC040515 |
|
Name of the company |
TRIVITRON DIAGNOSTICS PRIVATE LIMITED |
|
Address |
Trivitron Sapthagiri Bhavan, No. 15 Street, Abhiramapuram, Chennai – 600018, Tamilnadu. |
|
This Form is for |
Creation of charge |
|
Type of Charges |
Movable property |
|
Particular of the charge holder
|
HDFC Bank Limited Address: HDFC Bank Houses Senapati Bapat Marg, Lower Parel, Mumbai – 400 013 Email ID: srinivasan.venkatatraman@hdfcbank.com |
|
Nature or description of the instrument creating charge |
Memorandum relating to hypothecation of machinery dated 1st August 2007 |
|
Date of the instrument creating charge |
01.08.2007 |
|
Amount Secure by the charge |
Rs. 100.000 millions |
|
Brief of the principal terms and conditions and extent and operation
of the charge |
Rate of Interests: Any such rate as may be advised to the company from time to time in respect of the credit facilities. Term of repayment: Repayable on Demand Margin: As may be prescribed by the bank from time to time for the credit facilities. Extent and operation of charge: Hypothecation by way first exclusive charge in favour of HDFC Bank Limited on all the movable Plant and Machinery of the company both present and future in respect of credit facilities granted / to be granted to the group company M/s. Trivitron Medical Systems Peivate4 limited total facilities aggregating to Rs. 100.000 millions. |
|
Shorts particulars of the
Property charged |
Hypothecation by way of First Exclusive Charge on all movable plant and machinery of the company both present and future (more particularly described in the attachment) |
|
Name of the
company |
TRIVITRON DIAGNOSTICS PRIVATE LIMITED |
||||||||||
|
Presented
By |
Sri G S K Velu ,
Managing Director |
||||||||||
|
1) Date and
description of instrument creating the change |
08.06.2000 –
agreement fro hypothecation of stock in trade, machinery, Book debts, bills
and all other movables 08.06.2000 –
General Counter Guarantee and indemnity covering several guarantees within
the sanctioned guaranteed Limit. 08.06.2000-
letter of hypothecation to secure time to time Trust Loan against goods. |
||||||||||
|
2) Amount secured
by the charge/amount owing on the securities of charge |
|
||||||||||
|
3) Short
particular of the property charged. If the property acquired is subject to
charge, date of the acquired of the property should be given |
· Hypothecation of diagnostics Equipment / Consumable in trade · Hypothecation of diagnostics equipment / Consumable covered under Import LCs/ BGs · Counter guarantee for BGs. |
||||||||||
|
4) Gist of the
terms and conditions and extent and operation of the charge. |
Interest for overdraft at 16.5% p.a + interest tax Margin 40% for overdraft Commission as per circular Instruction for BG and LC Margin 25% in Term Deposits and Tenor 90 days After sight for LC Collaterally to be secured by residential flat No. 4, 1st Floor, Krishna Apartments, 2A Warren Road, Mylapore, Chennai property standing in the name of Smt. G Gomathi Personal guarantee of directors and property owners OD SIT – limit are valid upto 14.04. 2001 |
||||||||||
|
5) Name and
Address and description of the person entitled to the charge. |
ING Vysya Bank Limited Address: 13/1, Karpagambal Nagar, Mylapore, Chennai -4 |
||||||||||
|
6) Date and brief description of instrument
modifying the charge |
30.06.2004 Agreement for hypothecation of stock in trade, machinery, book debts, bills and all other movables. |
||||||||||
|
7) Particulars of
modifications specifying the terms and conditions or the extent of operations
of the charge in which modification is made and the details of the
modification. |
Modification is consequent to charging of the entire fixed of the company to secure the adhoc Import LC limit of Rs. 36.000 millions and Adhoc BG limit of Rs. 3.600 millions sanctioned to group company Trivitron Medical Systems P. Limited. |
Fixed Assets:
· Machineries and Equipments,
· Furniture and Fittings,
· Buildings and Interior Decoration,
· Vehicles,
· Computers
· Capital work in progress etc.
WEBSITE DETAILS:
Company Profile:
Since its inception, subject has grown at a steady pace to become the largest medical technology company of Indian origin. And one amongst the Top 10 Medical Technology Brands in India.
Subject specializes in a comprehensive
range of medical device solutions covering the fields of imaging, cardiology, nephrology,
critical care, orthopaedics, anaesthesiology, intensive care, obstetrics and
gynaecology, radiology, urology, ophthalmology, gastroenterology, microbiology,
biochemistry, haematology, immunology, molecular biology, blood banking,
surgery, home care and geriatrics.
Their main focus is to help the
Indian markets identify their requirements, provide them a host of
international brands and indigenous options to choose from and aid them get
maximum value out of these brands through excellent service support and
continuous medical knowledge initiatives. They corroborate their commitment to
quality by associating with only the top international brands in the industry.
Their principal partners include names like Aloka, Fresenius, DPC,
Hamilton, Richard Wolf and Arthrex - brands synonymous with their fields of
specialisation, worldwide.
With 18 branch offices, over 100
dealers spread across the country and a 24/7 manned help line they try to make
every installation comes with its own dedicated support
team.
Every member of Subject is handpicked as much for their technical skills as
for their personality and service motivation. They train them to be positive
and always willing to go out of the way to solve the problems.
No wonder they have a
client retention rate of almost 90% - testimony to their service claims.
Their unique combination of resources, values and experience also
enables them to offer cutting-edge, turnkey solutions for the healthcare
sector. This includes consultancy
services for setting up hospitals, nursing
homes, clinical laboratories and research centres.
Subject has plans to diversify further into
medical instrumentation and hospital services to remain in sync with their
vision of becoming the complete partner in healthcare facilitation.
Accredition
All their products have USA FDA Accredition, CE Certification, and ISO Certification for their quality objectives.
Since its inception,
Subject has grown at a steady
pace to become one of the top 5 medical technology companies in India.
- Subject has already extended its sales and after sales service network to countries such as Srilanka, Nepal, Bangladesh, Seychelles, UAE and Kenya.
- Subject is
focused towards gaining acceptance in the developing world for Indian manufactured
medical technology products, thus positioning this industry as a
substantial outward looking industry in the
next 10 years. - The company
already has offices in Srilanka and Dubai and has plans to open offices in
other countries soon to focus on developing markets such as South-Asia,
South-east Asia, Middle-eastern and
African countries.
Star Trivitron
(Dubai)
Star Trivitron is a Joint Venture company established in
Dubai, UAE. It will be an extended marketing arm of Subject focused on
increasing the company's presence in the International market. Star Trivitron
will focus on
supplying medical devices, medical supplies and pharmaceutical products. This
new joint-venture company would penetrate the Middle Eastern and North African
Countries and will function as a large trading organization.
The JV partners ETA Star Group is a large business enterprise with Group
turnover of in excess of USD 2.5 Billion with presence in over 89 countries
with focus on Middle-East, South East Asia and African countries. Trivitron
hopes to use the infrastructure of ETA Group to establish brand presence of
Star Trivitron in Middle East / African countries to market International /
indigenously developed medical technology products.
Star Trivitron commenced commercial operations in August 2006 and already has signed distribution agreement with over 15 of Trivitron’s collaborators to market their products in UAE and other selected Middle Eastern countries. Subject holds 34% equity in STAR Trivitron and gets 5% of profits as Management Fee.
Some of their prominent corporate customer includes:
Government hospitals:
·
AIIMS (New Delhi)
·
JJ Hospital, KEM
Hospital (Mumbai)
·
JIPMER (Pondicherry)
·
Nizam's (Hyderabad)
·
PGI (Chandigarh)
·
SGPGI (Lucknow)
Private Hospitals like:
·
Apollo group
(across India)
·
B.M.Birla
(Kolkata)
·
Breach Candy
Hospital (Mumbai)
·
Hinduja's
hospitals (Mumbai)
·
Mallya Hospital
(Bangalore)
·
Manipal
Hospital (Bangalore)
Teaching Institutes like:
·
CMC (Vellore)
·
MS Ramiah
Hospital (Bangalore)
·
Sri Ramachandra
Medical College (Chennai)
and large referral laboratories
like SRL Ranbaxy, Metropolis, Nicholas Piramal, Vimta Path Labs and Dr.Lal's
Path Labs.
Subject has presence
across India, Srilanka, Nepal, Bangladesh, Maldives, Mauritius, Seychelles etc.
and all the major institutions across India use at least one of the company's
Products. Medical technology strides boldly into the future, it is becoming
increasingly critical for healthcare service providers to stay abreast.
Added to the ever-changing demographics, an increasing population and spiraling
costs a reliable technology partner becomes invaluable.
The company projects looks to be just that.
A company with the muscle of international brands and a heart that's all
India !
The company projects is
that partner who comes into every project bringing expertise on technology, equipment, protocol, spatial dynamics and of course cost effectiveness.
They make this possible through their teams of highly qualified professionals
led by people with over thirty years of
experience in the fields of marketing and medical technology.
The company has experience setting up complete
diagnostic labs, fully equipped Operation Theatres, state-of-the-art cardiac
care centres, high end ICUs, Imaging centres and Physiotherapy Clinics.
Their quality standards are vetted by their presence in most of the leading
healthcare institutions across the country. Some of the facilities where they
have executed projects include:
Nationwide:
Apollo Hospital Group Turnkey for entire
dialyser needs of Apollo Hospital Group, Clinical Laboratory package for
IMMULITE Analyser etc
In the South:
·
Sri Ramachandra
Medical College Hospital ( ICU / OPERATION ROOM/ DIALYSER )
·
Malar Hospital (
Clinical Laboratory )
·
Jawaharlal Institute
of Post Graduate Medical Education and Research Hospital ( Complete ICU
Ventilation )
·
K.G. Hospital (
Dialyser )
·
Christian Medical
College Hospital ( Dia / CL / ICU Complete package )
·
Mallya Hospital ( C.
LAB / DIA / ICU )
·
Manipal Hospital (
ICU Equipment Package )
·
MS Ramiah Hospital ( C Lab / Dia / Imaging center )
In the West:
·
PD Hinduja National Hospital ( Dia / ICU Equipment package )
·
Bombay Hospital ( Dialyser clinic for indoor facility )
In
the North:
·
All India Institute of Medical Sciences ( Clinical
package for cardio and neuro center )
·
Post Graduate Institute of Medical Sciences ( ICU Ventilation
package)
In
the East:
·
Suraksha Hospital ( Imaging / CL
PACKAGE )
Note : DIA :
Dialyser clinic
CL / C LAB : Clinical Laboratory
· And the Apollo Hospitals Group across India and neighbouring countries.
· All big names, All institutions famous for their penchant for quality healthcare. All the company Customers.
· ITM University Awards for Corporate Excellence
DPC AWARD For the companie's Highest Sales of
Immuulite1000 Instruments.
The company Bags
award for highest sales of the Immulite 1000 instruments (2006). Presented by
Dr. Doug Olson, President, DPC ISD, Cirrus, New Jersey at the Annual Banquet of
International Distributors Meeting 2006, the award acknowledged the efforts of
the Trivitron Diagnostics division in achieving the highest sales for the year
2006. The first award in the six years since it began the DPC business, Subject stands tall, breaking new grounds and
achieving new heights. An accomplishment that would have been truly impossible
without the committed and dedicated efforts of their team in the Diagnostics
Division.
Subject represents 30 international and indigenous brands
across more than 22 medical
specialties. For easier access they have grouped their 156 products into 7 divisions. Each
division is manned by highly trained and experienced Trivitronians speaking the
language across India and Sri Lanka.
Products:-
Critical Care
Presenting with some of the
biggest international brands in health care - Hamilton,
Nihon Kohden and Bio-Med.
Diagnostics
It
is one
of the first Indian companies to offer a comprehensive range of international products for Laboratory Diagnostics.
Imaging
subject imaging ensures that factors like Accuracy,
Consistency, Speed and Technology are assured by partnering
with several leading international brands.
Neurology
Trivitron Neurology offers the best product
range exclusively for Electroencephalographs and EP / EMG
measuring systems, developed by Nihon Kohden.
Renal Care
Trivitron RENAL CARE ensures that
factors like Safety, Efficiency,
Stability and Technology are assured by partnering with the
biggest international brand - Fresenius.
Surgical Technologies
When it comes to Surgical
Technologies , factors like equipment accuracy and reliability
are all important. And we ensure that have nothing to worry about. By
associating with top companies in the world - each with more than 100 years of
experience.
Trivitech
Trivitech Healthcare is one of the
Group companies and a subsidiary of subject offering consumables and hospital
supplies.
Manufacturing
Subject is at the forefront
of creating the first of its kind, world class manufacturing facility in India
at a sprawling 20 acre land near Chennai. Subject is investing over Rs 2500
millions in this facility with the financial participation by well known US
based Private Equity companies.
World renowned
shoulder surgeon in India for Live Clinical Workshops jointly organised by
Subject
|
Program: |
Shoulder Course
2006 – live workshop |
|
Organising Chairman: |
Dr David V.
Rajan |
|
Visiting Faculty: |
Dr Peter Campbell,
Perth, Australia |
|
Under the Auspices of: |
Coimbatore Orthopaedic Society, Shoulder
Society of India and Tamilnadu Orthopaedic Association Shoulder Clinic,
GKNM Hospital, Coimbatore. |
|
Joint Organizers: |
Trivitron
Medical Systems |
|
Venue: |
G.K.D
Auditorium, GKNM Hospital, Coimbatore. |
|
Date: |
28th February
and 1st March 2006. |
|
|
|
|
Program: |
Bombay Shoulder
Course – live workshop - a comprehensive update on problems affecting the
shoulder joint. |
|
Course Director: |
Dr Sanjay Desai |
|
Course Organizer: |
Dr Sanjay Garude |
|
Visiting Faculty: |
Dr Peter
Campbell, Perth, Australia |
|
Under the Auspices of: |
Shoulder Society
of India |
|
Joint Organizers: |
Trivitron
Medical Systems |
|
Venue: |
Jaslok Hospital,
Mumbai. |
|
Date: |
2nd March 2006. |
|
|
|
|
Program: |
Shoulder Course – live workshop
- a comprehensive update on problems affecting the shoulder joint. |
|
Course Director: |
Kanchan
Battacharya |
|
Visiting Faculty: |
Dr Peter
Campbell, Perth, Australia |
|
Joint Organizers: |
Trivitron
Medical Systems |
|
Venue: |
AMRI Hospital,
Calcutta. |
|
Date: |
4th March 2006. |
|
|
|
|
Program: |
Shoulder Course – Oration on
Shoulder Joint Problems. |
|
Visiting Faculty: |
Dr Peter
Campbell, Perth, Australia |
|
Under the Auspices of: |
Tamilnadu
Orthopaedic Association. |
|
Joint Organizers: |
Trivitron
Medical Systems |
|
Venue: |
Chennai. |
|
Date: |
5th March 2006. |
Shoulder is a fascinating joint and shoulder problems pose great difficulties in daily life. Shoulder surgery has evolved into an exciting and result oriented specialty. With the new technique of arthroscopy the applications in Shoulder surgery have undergone a revolution.
The series of programs is conducted to highlight the importance of shoulder
surgery in India. The focus of the program is on clinical anatomy, shoulder
instability, rotator cuff tears, arthroscopy for shoulder joint, stiff and
frozen shoulder, sports injuries and shoulder replacement. The program would
cover lectures, live audio-visual relay of the surgery to the auditorium where
the attending surgeons can interact live with the operating surgeons and
discuss on the surgery as it is performed.
This gives an opportunity for a large audience of doctors to observe the new technique live without actually being present in the operation theatre.
Dr Peter Campbell – a world renowned shoulder surgeon is visiting India to
conduct these series of live clinical workshops and trainings on Shoulder Joint
Surgery.
The program is being organized jointly with M/s Trivitron Medical Systems – a
Rs. 1.0 Billion Corporate and one of the largest medical engineering companies
in India and abroad. Subject is one of
the leaders in technical support for Arthroscopy equipment and are associated
with M/s Arthrex, USA who are the world renowned arthroscopy companies.
Milestones:-
Started representing Hamilton Medical AG in 1997, after they had been here for 10 years and had only one major installation - Their ventilators are now a part of every major medical teaching institute and corporate hospital in the country.
Have successfully executed huge orders like US $ 1.7 million order of HIV kits
for NACO and US $ 500,000 order of Ventilators for PGIMER,
Chandigarh.
Have become the one source dialysis solution provider for Apollo Group across
India.
Introduced and stabilized Aloka Colour Doppler product line in India.
Are market leaders in Dialysis and Arthroscopy.
· No.1 Immunoassay supplier in India - have a presence in every referral lab of repute in the country.
· Have added a Neurology product line.
· Have added Endoscopy and Physiotherapy product lines.
· Have added high end imaging products to our product basket as well.
Beloved
Managing Director Dr Velu
has been nominated and selected by a team of Top Management Professionals to
receive ITM University Awards for Corporate Excellence title with a Citation
and a Trophy. Prof. P V Ramana, Chairperson, ITM University will be confer this
award of esteem to Dr Velu.
ITM University, a
dynamic group founded under the Iconic and Visionary Leadership of Prof. P V
Ramana, which has achieved the Spirit of Excellence in the truest sense of the
term. The ITM Group of Business Schools has grown from one Business School in
Mumbai, to 7 campuses. Starting with a 2 year fulltime MBA program in 1991, The
ITM Group of Business Schools is currently conducting 15 programs, in a broad
range of fields including Financial Markets, Retail, Pharmaceuticals,
Healthcare, Risk Management, Human Resources etc
ITM University Awards for Corporate Excellence is conferred on professionals
who have achieved tremendously in the fields they represent. They are role
models, cheer leaders, nurturer of talents and professionals with a TRACK
RECORD. This year is especially challenging with India Shining for Corporate
Czars and Leaders, who believe in “MAD” approach - which is Making a
Difference.
Dr Velu is
one such professional who has been recognized and certified to receive this
award.
The Program: ITM Awards for Corporate Excellence
Venue: Hotel Taj Connemara, Chennai
Date & Timing: 2nd December 2006 - 7:00 pm onwards followed by
Cocktails & Dinner
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject are
derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.47.67 |
|
UK Pound |
1 |
Rs.75.47 |
|
Euro |
1 |
Rs.61.19 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
8 |
|
PAID-UP CAPITAL |
1~10 |
8 |
|
OPERATING SCALE |
1~10 |
8 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
8 |
|
--PROFITABILIRY |
1~10 |
8 |
|
--LIQUIDITY |
1~10 |
8 |
|
--LEVERAGE |
1~10 |
8 |
|
--RESERVES |
1~10 |
8 |
|
--CREDIT LINES |
1~10 |
8 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
72 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational size
(10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|